ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko03040	Spliceosome	11/104	145/7206	6.72840407661e-06
ko05322	Systemic lupus erythematosus	10/104	151/7206	5.85561965834e-05
ko04110	Cell cycle	9/104	145/7206	0.000228402598958
ko05206	MicroRNAs in cancer	9/104	177/7206	0.000983447379498
ko04111	Cell cycle - yeast	6/104	90/7206	0.00182745220487
ko05203	Viral carcinogenesis	11/104	277/7206	0.00206555481894
ko05034	Alcoholism	10/104	238/7206	0.00219207571957
ko03440	Homologous recombination	4/104	41/7206	0.00275146350803
ko04113	Meiosis - yeast	5/104	70/7206	0.00327322114381
ko03018	RNA degradation	5/104	84/7206	0.00712581533954
ko04392	Hippo signaling pathway -multiple species	3/104	31/7206	0.00979067515637
ko04114	Oocyte meiosis	6/104	139/7206	0.0149838592911
ko05202	Transcriptional misregulation in cancer	7/104	188/7206	0.0186518096348
ko03450	Non-homologous end-joining	2/104	15/7206	0.0191664090532
ko03022	Basal transcription factors	3/104	44/7206	0.0252175647614
ko03008	Ribosome biogenesis in eukaryotes	4/104	79/7206	0.0269524319762
ko05200	Pathways in cancer	13/104	492/7206	0.0294131824471
ko05131	Shigellosis	4/104	82/7206	0.0303729350874
ko05220	Chronic myeloid leukemia	4/104	85/7206	0.0340392747418
ko03460	Fanconi anemia pathway	3/104	51/7206	0.0369013119435
ko05166	HTLV-I infection	9/104	292/7206	0.0378277377838
ko00261	Monobactam biosynthesis	1/104	3/7206	0.0426812121269
ko04310	Wnt signaling pathway	6/104	181/7206	0.0464244627881
ko04120	Ubiquitin mediated proteolysis	5/104	138/7206	0.0488765643262
ko05211	Renal cell carcinoma	4/104	96/7206	0.0496072409786